Cargando…

Baseline nocturnal glucose change: A predictor of the treatment effect of bolus intensification in insulin‐treated type 2 diabetes

This post hoc analysis of an 18‐week randomized trial explored the utility of calculating baseline glycated haemoglobin (HbA1c), postprandial glucose (PPG) increments and nocturnal glucose change in predicting efficacy and safety outcomes in response to bolus insulin intensification in people with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peters, Anne L., Piletič, Milivoj, Ejstrud, Johan, Salvesen‐Sykes, Karen, Snyder, James, Bowering, Keith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2019
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618272/ https://www.ncbi.nlm.nih.gov/pubmed/30924578 http://dx.doi.org/10.1111/dom.13729

Ejemplares similares

Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc Analysis
por: Bowering, Keith, et al.
Publicado: (2018)

Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy
por: Abrahamson, Martin J., et al.
Publicado: (2012)

Intensification of IDegAsp Twice Daily (Adding Insulin Aspart vs. Switching To Basal–Bolus): Exploratory Randomized Trial in Type 2 Diabetes
por: Bebakar, Wan Mohamaed Wan, et al.
Publicado: (2016)

The effect of basal–bolus therapy varies with baseline 1,5‐anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis
por: Heller, S., et al.
Publicado: (2018)

Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs: When and for whom?
por: Mosenzon, Ofri, et al.
Publicado: (2013)

Adding fast‐acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes: A randomized, 18‐week, open‐label, phase 3 trial (onset 3)
por: Rodbard, Helena W., et al.
Publicado: (2017)

Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?
por: Mitsuishi, Sumie, et al.
Publicado: (2015)

Differential Treatment Response to Insulin Intensification Therapy: A Post Hoc Analysis of a Randomized Trial Comparing Premixed and Basal-Bolus Insulin Regimens
por: Shi, Li Xin, et al.
Publicado: (2017)

A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes
por: Linjawi, Sultan, et al.
Publicado: (2017)

Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study
por: Pfohl, Martin, et al.
Publicado: (2015)

Patterns and predictors of antihyperglycemic intensification at hospital discharge for type 2 diabetic patients not on home insulin
por: Abusamaan, Mohammed S., et al.
Publicado: (2020)

Treatment intensification using long-acting insulin –predictors of future basal insulin supported oral therapy in the DIVE registry
por: Danne, Thomas, et al.
Publicado: (2015)

Five Simple Steps to Optimize Bolus Insulin Therapy in Type 2 Diabetes
por: Peters, Kyle R., et al.
Publicado: (2017)

Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data
por: Peters, Anne, et al.
Publicado: (2020)

Mealtime fast‐acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin‐resistant Type 2 diabetes
por: Bowering, K., et al.
Publicado: (2018)

A basal-bolus insulin regimen integrated microneedle patch for intraday postprandial glucose control
por: Chen, Bo Zhi, et al.
Publicado: (2020)

Pasta Structure Affects Mastication, Bolus Properties, and Postprandial Glucose and Insulin Metabolism in Healthy Adults
por: Vanhatalo, Saara, et al.
Publicado: (2021)

Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes
por: Tauschmann, Martin, et al.
Publicado: (2017)

Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring
por: Abe, Shinya, et al.
Publicado: (2011)

Short Report: Treatment Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal–bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal–Bolus Type 1): 2-year results of a randomized clinical trial
por: Bode, B W, et al.
Publicado: (2013)

Nocturnal Choking, as an Isolated Manifestation of Epilepsy
por: Bashir, Ahsan, et al.
Publicado: (2016)

Investigation of Nocturnal Hypokinesia and Health-Related Quality of Life in Parkinsonian Patients with the Korean Version of the Nocturnal Hypokinesia Questionnaire
por: Choi, Ji-Hyun, et al.
Publicado: (2021)

Glucose Meters with Built-In Automated Bolus Calculator: Gadget or Real Value for Insulin-Treated Diabetic Patients?
por: Colin, Ides M., et al.
Publicado: (2012)

Basal–Bolus Insulin Therapy with Gla-300 During Hospitalization Reduces Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study
por: Okajima, Fumitaka, et al.
Publicado: (2018)

Nocturnal melatonin increases glucose uptake via insulin-independent action in the goldfish brain
por: Watanabe, Kazuki, et al.
Publicado: (2023)

Efficacy of bolus insulin calculation by a mobile-based bolus advisor: An open label clinical trial
por: Siavash, Mansour, et al.
Publicado: (2015)

Extended insulin boluses cannot control postprandial glycemia as well as a standard bolus in children and adults using insulin pump therapy
por: Lopez, Prudence, et al.
Publicado: (2014)

Measurement of Esophageal Nocturnal Baseline Impedance: A Simplified Method
por: Hoshikawa, Yoshimasa, et al.
Publicado: (2020)

A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study
por: Hanžel, Jurij, et al.
Publicado: (2015)

Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
por: Bergenstal, Richard M., et al.
Publicado: (2019)

Improvement in glycemia after glucose or insulin overload in leptin-infused rats is associated with insulin-related activation of hepatic glucose metabolism
por: Burgos-Ramos, Emma, et al.
Publicado: (2016)

Fasting plasma glucose level-based formula for estimating starting daily dose in basal-bolus insulin therapy
por: Nagao, Mototsugu, et al.
Publicado: (2023)

Role of Emerging Insulin Technologies in the Initiation and Intensification of Insulin Therapy for Diabetes in Primary Care
por: Brunton, Stephen A., et al.
Publicado: (2016)

Preventive effect of ipragliflozin on nocturnal hypoglycemia in patients with type 2 diabetes treated with basal‐bolus insulin therapy: An open‐label, single‐center, parallel, randomized control study
por: Okajima, Fumitaka, et al.
Publicado: (2016)

Bolus versus continuous insulin infusion in immediate postoperative blood glucose control in liver transplantation: pragmatic clinical trial
por: Fragoso, Luciana Vládia Carvalhêdo, et al.
Publicado: (2022)

Insulin initiation and intensification in patients with T2DM for the primary care physician
por: Unger, Jeff
Publicado: (2011)

Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43)
por: Schrijnders, Dennis, et al.
Publicado: (2016)

Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review
por: Meece, Jerry
Publicado: (2018)

Treatment of Monosymptomatic Nocturnal Enuresis: Sertraline for Non-Responders to Desmopressin
por: Mahdavi-Zafarghandi, Reza, et al.
Publicado: (2014)

Missed Insulin Boluses for Snacks in Youth With Type 1 Diabetes
por: VanderWel, Brandon W., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_m216cci5le3i2gqv56fdo87iq2